» Authors » Meritxell Valenti

Meritxell Valenti

Explore the profile of Meritxell Valenti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 135
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lo J, Crawford J, Lipnicki D, Lipton R, Katz M, Preux P, et al.
JAMA Netw Open . 2024 Oct; 7(10):e2437133. PMID: 39356504
Importance: Poststroke cognitive impairment is common, but the cognitive trajectory following a first stroke, relative to prestroke cognitive function, remains unclear. Objective: To map the trajectory of cognitive function before...
2.
Del Ser T, Valeriano-Lorenzo E, Janez-Escalada L, Avila-Villanueva M, Frades B, Zea M, et al.
Front Dement . 2024 Jul; 2:1099059. PMID: 39081990
Background: The relative importance of different components of cognitive reserve (CR), as well as their differences by gender, are poorly established. Objective: To explore several dimensions of CR, their differences...
3.
Sanchez-Juan P, Valeriano-Lorenzo E, Ruiz-Gonzalez A, Pastor A, Rodrigo Lara H, Lopez-Gonzalez F, et al.
Brain . 2024 Apr; 147(5):1667-1679. PMID: 38634687
Glial fibrillary acidic protein (GFAP), a proxy of astrocyte reactivity, has been proposed as biomarker of Alzheimer's disease. However, there is limited information about the correlation between blood biomarkers and...
4.
Del Ser T, Fernandez-Blazquez M, Valenti M, Zea-Sevilla M, Frades B, Alfayate E, et al.
Gerontology . 2021 Jan; 67(3):281-289. PMID: 33429394
Background: The older population has been especially affected by the severe acute respiratory syndrome coronavirus 2 pandemic (COVID-19). Objective: The aim of the study was to explore the incidence, severity,...
5.
Bermejo-Pareja F, Del Ser T, Valenti M, De la Fuente M, Bartolome F, Carro E
Alzheimers Dement . 2020 Jun; 16(8):1196-1204. PMID: 32543760
Objective: We aim to explain why salivary lactoferrin (Lf) levels are reduced in patients suffering mild cognitive impairment (MCI) and sporadic Alzheimer's disease (sAD). We also will discuss if such...
6.
Del Ser T, Zea M, Valenti M, Olazaran J, Lopez-Alvarez J, Rebollo-Vazquez A, et al.
J Psychopharmacol . 2019 Jun; 33(8):965-974. PMID: 31241413
Background: Chronic drug intake has been associated with negative and positive cognitive effects in elderly people, although subjacent conditions may be confounding factors. Aim: To study the effects on cognitive...
7.
Avila-Villanueva M, Rebollo-Vazquez A, Ruiz-Sanchez de Leon J, Valenti M, Medina M, Fernandez-Blazquez M
Front Aging Neurosci . 2016 Oct; 8:233. PMID: 27757082
: Subjective memory complaints (SMC) in the elderly have been suggested as an early sign of dementia. This study aims at investigating whether specific cognitive complaints are more useful than...
8.
Olazaran J, Valenti M, Frades B, Zea-Sevilla M, Avila-Villanueva M, Fernandez-Blazquez M, et al.
Front Aging Neurosci . 2015 Oct; 7:181. PMID: 26483681
Introduction: Alzheimer's disease (AD) is a major threat for the well-being of an increasingly aged world population. The physiopathological mechanisms of late-onset AD are multiple, possibly heterogeneous, and not well...
9.
Pastor P, Moreno F, Clarimon J, Ruiz A, Combarros O, Calero M, et al.
J Alzheimers Dis . 2015 Oct; 49(2):343-52. PMID: 26444794
The MAPT H1 haplotype has been linked to several disorders, but its relationship with Alzheimer's disease (AD) remains controversial. A rare variant in MAPT (p.A152T) has been linked with frontotemporal...
10.
Olazaran J, Ramos A, Boyano I, Alfayate E, Valenti M, Rabano A, et al.
Am J Alzheimers Dis Other Demen . 2014 Jan; 29(3):263-9. PMID: 24408753
Objective: A cross-sectional study was conducted to describe the prevalence, locations, and risk factors for brain microbleeds (BMBs) in neurodegenerative dementia. Methods: The database of the Alzheimer Center Reina Sofía...